Zdrowie i gospodarka · 28/11/2006

FDA Extends Comment Period for Draft Guidance on Commercially Distributed ASRs

The Food and Drug Administration (FDA) is extending the comment period for its draft guidance on Commercially Distributed Analyte Specific Reagents (ASRs) until a later date, following the initial closing on December 6, 2006, after announcing its availability in the Federal Register on September 7, 2006.